ACN
47
-2
HUM
48
6
TEL
60
2
EW
37
-2
L
62
2
DTE
50
3
DD
56
3
PBI
60
-5
EOG
58
2
IVZ
46
3
DG
2
-6
NI
75
2
ALLE
37
5
STI
47
-12
USB
50
2
DHI
48
3
EIX
77
2
SCHW
64
2
TRV
53
-3
AA
51
3
ACN
47
-2
HUM
48
6
TEL
60
2
EW
37
-2
L
62
2
DTE
50
3
DD
56
3
PBI
60
-5
EOG
58
2
IVZ
46
3
DG
2
-6
NI
75
2
ALLE
37
5
STI
47
-12
USB
50
2
DHI
48
3
EIX
77
2
SCHW
64
2
TRV
53
-3
AA
51
3
Financhill
Back

Kazia Therapeutics Quote, Financials, Valuation and Earnings

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.
Buy
64

KZIA
Kazia Therapeutics

Last Price:
5.77
Seasonality Move:
12.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Kazia Therapeutics Price Quote

$5.77
+0.16 (+2.85%)
(Updated: November 21, 2024 at 10:30 AM ET)

Kazia Therapeutics Key Stats

Buy
64
Kazia Therapeutics (KZIA) is a Buy
Day range:
$5.50 - $6.01
52-week range:
$1.87 - $15.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
41.1K
Avg. volume:
171.8K
1-year change:
-27.3%
Market cap:
$16.9M
Revenue:
$1.5M
EPS:
$-6.67

How Much Does Kazia Therapeutics Make?

Data Unavailable

Is Kazia Therapeutics Growing As A Company?

  • What Is Kazia Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.96%
  • What Is Kazia Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Kazia Therapeutics Stock Price Performance

What Is Kazia Therapeutics 52-Week High & Low?

Kazia Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Kazia Therapeutics?

  • How Much Debt Does Kazia Therapeutics Have?
    Total long term debt quarterly is $423.8K
  • How Much Cash Does Kazia Therapeutics Have?
    Cash and short term investments quarterly total is $1.1M
  • What Is Kazia Therapeutics’s Book Value Per Share?
    Book value per share is -2.01

Is Kazia Therapeutics Cash Flow Positive?

  • What Is KZIA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$6.3M
  • What Is Kazia Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $3.9M
  • What Is Kazia Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Kazia Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    KZIA return on invested capital is -784.09%
  • What Is Kazia Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -106.28%
  • What Is KZIA Return On Equity?
    ROE is a measure of profitability and is -1083.16%

Kazia Therapeutics Earnings Date & Stock Price

Kazia Therapeutics Competitors

Kazia Therapeutics Dividend Yield

Kazia Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: -95.91% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 19.98
Upside from Last Price: 256.2%

Major Shareholders

  • How many KZIA shares are owned by institutional investors?
    5.1M KZIA shares are owned by institutional investors
  • How many KZIA shares are owned by insiders?
    19.8K KZIA shares are owned by insiders